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Abstract
Tracers injected into CSF pass into the brain alongside arteries and out again. This has been recently termed the “glymphatic 
system” that proposes tracers enter the brain along periarterial “spaces” and leave the brain along the walls of veins. The 
object of the present study is to test the hypothesis that: (1) tracers from the CSF enter the cerebral cortex along pial-glial 
basement membranes as there are no perivascular “spaces” around cortical arteries, (2) tracers leave the brain along smooth 
muscle cell basement membranes that form the Intramural Peri-Arterial Drainage (IPAD) pathways for the elimination of 
interstitial fluid and solutes from the brain. 2 μL of 100 μM soluble, fluorescent fixable amyloid β (Aβ) were injected into 
the CSF of the cisterna magna of 6–10 and 24–30 month-old male mice and their brains were examined 5 and 30 min later. 
At 5 min, immunocytochemistry and confocal microscopy revealed Aβ on the outer aspects of cortical arteries colocalized 
with α-2 laminin in the pial-glial basement membranes. At 30 min, Aβ was colocalised with collagen IV in smooth muscle 
cell basement membranes in the walls of cortical arteries corresponding to the IPAD pathways. No evidence for drainage 
along the walls of veins was found. Measurements of the depth of penetration of tracer were taken from 11 regions of the 
brain. Maximum depths of penetration of tracer into the brain were achieved in the pons and caudoputamen. Conclusions 
drawn from the present study are that tracers injected into the CSF enter and leave the brain along separate periarterial base-
ment membrane pathways. The exit route is along IPAD pathways in which Aβ accumulates in cerebral amyloid angiopathy 
(CAA) in Alzheimer’s disease. Results from this study suggest that CSF may be a suitable route for delivery of therapies for 
neurological diseases, including CAA.
Keywords Intramural periarterial drainage · Basement membranes · Interstitial fluid · Cerebrospinal fluid · Glymphatic
Introduction
Apart from blood, there are two major extracellular fluids 
associated with the brain and spinal cord, namely CSF in 
the ventricles and subarachnoid spaces, and interstitial fluid 
(ISF) in the extracellular spaces of the brain and spinal cord. 
CSF and ISF appear to drain from the brain along largely 
separate pathways to regional lymph nodes [11]. Tracers 
injected into the CSF drain from the subarachnoid space 
to cervical lymph nodes by channels that pass through the 
cribriform plate and join lymphatic channels in the nasal 
submucosa [18, 20, 27]. Similarly, there is lymphatic drain-
age of CSF alongside cranial and spinal nerves and into lym-
phatics in the dura mater [3, 8, 11, 22].
There are no conventional lymphatic vessels in the brain 
parenchyma, but there is lymphatic drainage of ISF to 
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cervical lymph nodes [11, 39]. When minute amounts of 
radioactive tracer are injected into deep grey matter of the rat 
brain, they drain to cervical lymph nodes along the walls of 
cerebral and intracranial arteries [39]. High-resolution stud-
ies using formalin-fixable fluorescent tracers suggest that the 
drainage pathways for ISF and solutes from the brain are the 
basement membranes in the walls of cerebral capillaries and 
arteries [4]. Injection of fluorescent tracer in small amounts 
of 0.5 µL through fine 50 μm glass cannulae ensures that no 
tracer leaks into the CSF [4]. At 5 min following these injec-
tions, tracers are within the basement membranes of cerebral 
capillaries and in basement membranes around smooth mus-
cle cells in the tunica media of cerebral arteries. By 30 min 
post-injection, no tracer remains in basement membranes 
in the walls of capillaries or arteries, but the course of each 
artery involved is outlined by perivascular macrophages con-
taining tracer [4].
Flow of tracer along smooth muscle cell basement mem-
branes in the walls of arteries has been demonstrated by 
in vivo multiphoton imaging [2]. Ultrastructural studies have 
shown that, following injection of soluble amyloid-β (Aβ) 
into the mouse brain as a tracer, Aβ pervades the extracel-
lular spaces of the brain and is in continuity with Aβ within 
capillary basement membranes [24]. In artery walls, how-
ever, tracer injected into the brain parenchyma is confined 
to basement membranes surrounding smooth muscle cells 
in the tunica media and is not observed in basement mem-
branes associated with either endothelial cells or with pial-
glial basement membranes on the external aspects of the 
tunica media [4]. It appears, therefore, that tracer is unlikely 
to enter artery walls either via the endothelium or radially 
from the brain parenchyma through the glia limitans. From 
these observations, it appears that tracers in the ISF pass 
from the brain parenchyma into basement membranes of 
capillaries and flow out of the brain along smooth muscle 
cell basement membranes in the walls of arteries [2, 4]. This 
pathway has been termed the intramural peri-arterial drain-
age (IPAD) pathway. The relevance of IPAD to neurode-
generative disease in humans is emphasized by the pattern 
of deposition of Aβ in the walls of cerebral capillaries and 
arteries as cerebral amyloid angiopathy (CAA). In the early 
stages of CAA, the pattern of deposition of Aβ corresponds, 
exactly, with the IPAD pathways identified by fluorescent 
tracer studies in the mouse [14, 19, 29].
Although tracers and Aβ in CAA outline the endothelial/
glial basement membranes around capillaries, tracers and Aβ 
are limited to basement membranes around smooth muscle 
cells in the tunica media of arteries within the brain and 
leptomeninges. Neither the endothelial basement membranes 
nor the outer pial-glial basement membranes are outlined by 
tracer or by the deposition of Aβ [4].
There is, therefore, evidence from experimental studies 
and from CAA that IPAD is a physiological pathway for 
drainage of ISF and solutes from the brain. Evidence from 
radioactive tracer studies [36] and from the drainage of Aβ 
from the brain [26] strongly support the concept that the 
IPAD route is the lymphatic drainage pathway for ISF and 
solutes from rodent and human brain. Radioactive tracers 
injected into the brain are present in the walls of intracranial 
arteries but not in the carotid artery in the neck [36]. Fur-
thermore, biochemical analyses of Aβ in the walls of human 
arteries from 20 years of age onwards detected increasing 
amounts of Aβ in the walls of intracranial arteries with age 
but very little Aβ was detected at any age in the extracranial 
carotid arteries in the neck [33]. These results would corre-
late with Aβ draining from the brain along artery walls and 
passing to lymph nodes closely applied to the carotid artery 
below the base of the skull [7].
Despite the largely separate drainage pathways for CSF 
and ISF, the two fluids do mix within the brain. Tracers 
injected into the CSF pass into the brain and spinal cord 
tissue along the outer aspects of arteries and this system 
has been variously named as convective tracer influx and 
the glymphatic system [17, 30]. Electron microscope stud-
ies have shown that there are no perivascular spaces around 
arteries in the cerebral cortex [23, 37, 40] although dilated 
perivascular spaces do develop in other parts of the brain 
such as cerebral white matter and the basal ganglia [32]. 
Perivascular spaces in the basal ganglia have been demon-
strated by electron microscopy [28].
When nanoparticles are injected as tracers into the CSF 
of mice, they appear to pass into the brain along the base-
ment membrane between the coatings of pia mater on the 
outer aspect of cortical arteries and the glia limitans on the 
surface of the brain, the pial-glial basement membrane [24]. 
Previous studies have suggested that tracers injected into the 
CSF pass into the brain along assumed periarterial “spaces” 
and drain out of the brain along the walls of veins [17]. Hav-
ing defined by electron microscopy the most probable entry 
pathway for particulate tracers passing into the brain from 
the CSF as the pial-glial basement membrane, we used injec-
tions of tracer into the CSF of the cisterna magna of mice 
to achieve three objectives. Our first two major objectives 
in the present study are: (1) to demonstrate by immunocy-
tochemistry that the pial-glial basement membranes are the 
entry route into the brain for soluble tracers from the CSF 
and (2) to test the hypothesis that tracers entering the brain 
from the CSF drain out of the brain parenchyma along the 
IPAD pathways. Groups of mice were examined 5 min and 
30 min after injection of fluorescent Aβ tracer into the cis-
terna magna of young 2–10-week- and aged 24–30-month-
old mice.
The third major objective in this study is to determine the 
range of depths of penetration of tracer alongside arteries 
in different regions of the brain and for the time points of 5 
and 30 min in young and aged mice. The importance of this 
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study relates to drug delivery from the CSF and will be dealt 
with further in the discussion.
Materials and methods
Animals
Male C57BL/6 mice 6–10 weeks (young) and 24–30 months 
(old) were housed at the Biomedical Research Facility 
(BRF) at Southampton General Hospital (Southampton, 
UK). All mice were housed in groups of 4–10. They were 
kept under standard 12-h light/dark cycle and fed a standard 
RM1 chow diet (SDS, UK) and water ad libitum. Environ-
mental enrichment consisted of wooden sticks, red plastic 
tunnels and other bedding. All procedures were carried out 
in accordance with animal care guidelines stipulated by the 
United Kingdom Animals (Scientific Procedures) Act 1986, 
Home Office licence (PPL 30/3095).
Anaesthesia
C57BL/6 mice were anaesthetised using a standard isoflu-
rane anaesthesia system. An anaesthesia induction chamber 
was precharged with 5% isoflurane for 5 min and the oxy-
gen flow meter was set to approximately 1.7 l min−1 with 
the indicator ball floating between the 1 and 2 hash marks. 
The isoflurane vaporizer was then reduced to 1–2% and the 
mouse was left in the chamber for 3–5 min. We chose iso-
flurane after our pilot experiments in n = 3 wild type mice 
determined that isoflurane did not reduce the heart rate or 
oxygen saturation in C57BL/6 mice to the same degree 
as our previous anaesthetic (ketamine and xylazine), see 
Online Resource 1. The level of anaesthesia was monitored 
using the pedal withdrawal reflex response. Once the mouse 
reached a surgical plane of anaesthesia (no reflex), it was 
transferred from the induction chamber onto a surgical bed 
with a breathing device and mask that supplied a constant 
flow of 1–2% isoflurane and 1.7 l min−1 oxygen to keep the 
animal safely anesthetised during the surgical procedure. 
The core body temperature was monitored using a rectal 
probe and maintained at 37 °C using an electronic heat-
ing pad. The cornea was protected using Lacri-Lube eye 
ointment.
Intracisternal injections
The mouse was placed prone on a stereotaxic frame and 
head-restrained with ear bars after the area between the 
head and shoulders was shaved. Under a dissection micro-
scope, a 10 mm midsagittal incision of the skin was made 
inferior to the occipital crest. To expose the dura cov-
ering the cisterna magna, the subcutaneous tissue and 
occipital muscles (biventer cervicis and rectus capitis 
dorsalis) were separated using blunt-ended forceps and 
the posterior atlanto-occipital membrane was incised. 
Using a cotton swab, the area was treated with a cotton 
bud impregnated with viscous glycerol to help prevent 
CSF reflux. A glass capillary micropipette (Sigma, UK) 
with an adjusted diameter (of < 50 μm, made using a Sut-
ter P97 Flaming Brown Pipette puller) was positioned 
perpendicular to the ear bars and advanced gently to pen-
etrate the dura until resistance was overcome indicating 
entry into the cisterna magna. The capillary had been 
loaded with 2 μl of 100 μM Aβ1-40 Hylite Fluor 555 
(Bioscience), which was injected over 2.5 min at a rate 
of 0.8 μl min−1. The microcapillary was left in situ for 
2 min to prevent reflux and mice were culled 5 or 30 min 
after withdrawal of the glass capillary through overdose 
with pentobarbital (200 mg kg−1). Mice were intracardi-
ally perfused with 0.01 M phosphate buffer saline (PBS) 
followed by 4% paraformaldehyde (PFA) in 0.01 M PBS 
at a rate of 5 ml min−1. Brains were dissected from the 
skull, post fixed in 4% PFA for 6–7 h and cryoprotected 
with 30% sucrose in 0.01 M PBS for 48 h. The brains 
were sectioned into 20-μm-thick coronal slices using a 
cryostat and stored at − 20 °C.
Double‑labeling immunofluorescence
For double-labelling immunohistochemistry, tissue sections 
were incubated overnight with anti-α-smooth muscle actin 
(SMA) FITC (1:200, Sigma-Aldrich, Dorset, UK) for the 
identification of arteries. Anti-collagen IV (1:400, ABCAM, 
Cambridge, UK) was used to mark the basement membranes 
of blood vessels (Thermo Fisher Scientific, Paisley, UK). 
Brain sections were also incubated with rat monoclonal 
anti-α-2 laminin (1:200) to identify the astrocyte basement 
membranes of the glia limitans abutting the outer aspect 
of cortical arteries [13] or mouse monoclonal anti-GFAP 
(1:100) or polyclonal rabbit anti-CD163 (1:100) at 4 °C 
for 24 h in a moist chamber. All primary antibodies were 
diluted in 0.1% PBST. Subsequently, sections were incu-
bated with the appropriate secondary antibodies conjugated 
to Alexafluor fluorophores. Photomicrographs of triple label-
ling immunohistochemistry were captured across the brain 
starting anterior from the olfactory bulbs moving posteriorly 
towards the cerebellum. Sections were analyzed using an 
SP8 confocal laser-scanning microscope (Milton Keys, UK) 
and exported to Image J software. Montages were created 
with Photoshop CS6.
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Cerebral blood vessel classification
Arteries were differentiated from veins using an SMA 
marker, which only stains the smooth muscle cells that are 
present in arteries and arterioles. Vessels that were nega-
tive for SMA and had a diameter < 10 μm were classified 
as capillaries.
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Quantitative assessment of Aβ‑positive blood 
vessels
To compare the depth of tracer 5 min and 30 min post-
intracerebral injection in young and old mice, the distance 
of the Aβ-positive blood arteries from the surface or base 
of the brain was measured by drawing two perpendicular 
lines (one travelling in the direction of the vessel and a tan-
gent of the surface/base of the brain; see Online Resource 2) 
and determining the distance of the vessel from the point at 
which the two lines meet. A total of 108 full coronal sections 
were analyzed in 6–10 week old mice (n = 3 per time point) 
and 56 sections in 24–30 month old mice (n = 3 per time 
point) and all the Aβ-positive blood SMA-positive arteries 
were quantified in this way. The sections quantified were 
taken at the level of the olfactory bulbs, cortex, ventricles, 
hippocampus, midbrain and cerebellum. The total length of 
each region (e.g., olfactory bulbs) was 180 μm.
Statistical analysis
The average of all distances in each brain region per mouse 
were used for statistics (n = 3/group). Data were checked 
for normality using the D’Agostino & Pearson omnibus and 
Shapiro–Wilk normality tests. As the data in some groups 
were not normally distributed, all values were  Log10 trans-
formed to obtain a normal distribution. One-way analysis 
of variance (ANOVA) with Sidak’s post hoc test was used 
to compare the distance at which Aβ was seen from the 
reference point at the surface of the brain within the same 
brain region at 5 and 30 min after intracisternal injections. 
Two-way ANOVA with Sidak’s post hoc test was used to 
compare the distance at which Aβ was seen from the refer-
ence point at the surface of the brain between young and old 
mice at 5 and 30 min after intracisternal injections. Statis-
tical analyses were performed using log-transformed data, 
with corresponding p values indicated on graphs that were 
generated using non-transformed data.
Results
Anatomical distribution of β‑amyloid after its 
injection into cisternal CSF
First, the possible route of entry of Aβ1-40 (referred to from 
here as Aβ) contained within the CSF into the brain of 6–10-
week old mice was evaluated by double-labelling immu-
nohistochemistry and confocal microscopy. The anatomical 
distribution of Aβ in the brain and the type of Aβ-positive 
blood vessels were determined by staining the sections with 
an SMA marker to differentiate arteries from veins, a general 
basement membrane marker (collagen IV) and a specific 
astrocytic basement membrane marker (α-2 laminin). The 
anatomical compartment in which the tracer was contained 
was defined and compared after 5 and 30 min of injection of 
tracer into the cisterna magna.
6–10‑week‑old mice, 5 min post‑injection
Aβ was detected within the walls of leptomeningeal and 
cortical arteries (Fig. 1). Immunocytochemistry with mul-
tiple labelling of collagen IV, α-2 laminin and Aβ tracer 
confirms the presence of Aβ tracer in the brain-disposed 
along pial-glial basement membranes on the outer aspects 
of arteries. Figure 1a shows a blood vessel penetrating the 
cerebral cortex with Aβ tracer, stained red, in the vessel wall. 
Co-localisation of Aβ tracer and α-2 laminin in the pial-glial 
basement membrane is shown as yellow. Co-localisation of 
Aβ tracer and collagen IV in the artery wall is depicted as 
fuchsia pink. At higher magnification in Fig. 1b, α-2 laminin 
in the astrocyte basement membranes of the glia limitans on 
the surface of the brain is stained green and co-localisation 
of Aβ and α-2 laminin wall of the artery is shown as yellow. 
Confirmation that the Aβ tracer is in basement membranes 
on the outer aspect of arteries 5 min after injection into the 
CSF is seen in Fig. 1c. The blood vessel in longitudinal view 
is identified as an artery by the presence of smooth muscle 
cells stained green for smooth muscle actin in its wall. Aβ 
tracer co-localizes with collagen IV (blue) as a fuchsia pink 
colour in a single fine layer of basement membrane on the 
outer aspects of the artery. This corresponds to the position 
on the outer aspect of the artery to the pial-glial basement 
membrane [24].
Fig. 1  Anatomical entry route of Aβ into the young adult brain from 
the CSF at 5 and 30 min post-injection. Young 6–10-week-old mice: 
Entry of amyloid-β (Aβ) tracer into the brain from the CSF at 5 min 
(a–c). Drainage of Aβ tracer from the brain along the walls of arter-
ies at 30 min (d–l). a 5 min: the surface of the cerebral cortex (blue 
line) and a cortical artery passing into the brain with Aβ tracer red 
in its walls. Aβ tracer colocalized with α2-laminin in the pial-glial 
basement membrane (yellow) indicated by the white arrow. b 5 min: 
a single optical section of the artery enclosed in the box in a show-
ing α2-laminin in the astrocyte basement membrane of the glia limi-
tans on the surface of the brain (green) and co-localisation of Aβ and 
α2-laminin in the pial-glial basement membrane on the outer aspect 
of the wall of the artery (yellow) (white arrow); c 5 min: the profile 
of a cortical artery with smooth muscle cells (green) in its wall shows 
Aβ tracer (red) colocalized (pink) with collagen IV (blue) in the pial 
basement membrane on the outer surface of the artery (white arrows). 
At 30 min after injection as shown in figures (d–l), the distribution 
of the Aβ in the artery walls is very different from that seen at 5 min 
in figures (a–c). d An artery identified by green smooth muscle actin 
in its wall (f, j) shows Aβ tracer (red, e, k) colocalized (pink) with 
collagen IV (blue, g, l) within the wall of the artery in a spiral or lad-
der-type distribution (arrows in d), closely resembling the pattern of 
deposition of Aβ in the walls of arteries as cerebral amyloid angiopa-
thy (CAA); h a single optical section from the artery in d) showing 
the Aβ tracer (red) between the smooth muscle actin staining (green)
◂
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6–10‑week‑old mice, 30‑min post injection
Aβ was detected in the basement membranes surrounding 
smooth muscle cells within the walls of leptomeningeal and 
cortical arteries but not in the walls of capillaries and veins. 
The vessel in longitudinal view in Fig. 1d is an artery identi-
fied by the smooth muscle cells in its wall stained green by 
α smooth muscle cell actin (Figs. 1d, f, j). At 30 min after 
injection into the cisterna magna, Aβ tracer (Fig. 1e, k) 1 
is seen in a spiral configuration that represents the smooth 
muscle cell basement membranes within the artery wall; the 
fuchsia pink staining (Fig. 1d, i) represents co-localisation 
of Aβ tracer in the walls of arteries in Fig. 1e, k and col-
lagen IV in the smooth muscle cell basement membranes 
(Fig. 1g, j, l). In a single optical section from an arteriole, 
fuchsia pink colocalisation of collagen IV and Aβ is seen 
running between green-stained smooth muscle cells in the 
tunica media of the arteriole (Fig. 1h).
24–30 month old mice, 5‑min post injection
At 5 min following injection of Aβ tracer into the cis-
terna magna, the distribution of tracer is similar in 
the 24–30-month-old mice to that found in the young 
6–10-week-old mice. Aβ tracer was observed in the walls of 
arterioles, as depicted by immunostaining for green smooth 
muscle actin in Figs. 2a, and b and in the walls of capillaries, 
as shown in Fig. 2c. In Fig. 2d, a blood vessel penetrating 
the surface of the cerebral cortex shows Aβ tracer within 
the vessel wall and co-localizing with α-2 laminin indicat-
ing its presence in the pial-glial basement membrane on the 
abluminal aspect of the vessel. At higher magnification in 
a single channel image in Fig. 2e, and f, α-2 laminin in the 
glia limitans on the surface of the brain is stained green. 
Co-localisation of α-2 laminin and Aβ tracer in the pial-glial 
basement membrane on the outer aspect of the vessel wall 
is depicted in yellow.
24–30‑month‑old mice, 30 min post injection
The pattern of distribution of Aβ tracer in the walls of blood 
vessels in the older mice at 30 min after intracisternal injection 
is slightly different from that in the young mice. With regard to 
the arteries, the distribution of Aβ tracer is the same in the two 
age groups. Figure 3a shows an artery and vein at the surface 
of the cerebral cortex. The artery is identified by the staining 
of smooth muscle cells in its wall; Aβ is present in the same 
spiral pattern as smooth muscle cell basement membranes in 
the tunica media. A leptomeningeal artery in Fig. 3a, b shows 
the corresponding spiral pattern of smooth muscle cells in the 
tunica media. Aβ tracer is present in a short region of the wall 
of a vein near the subarachnoid space in Fig. 3a. Aβ tracer, red, 
colocalizes with cells stained green for the macrophage marker 
CD 163 (Fig. 3c). In addition, Aβ tracer co-localizes with glial 
fibrillary acidic protein (GFAP) in perivascular astrocyte pro-
cesses in Fig. 3d.
Periarterial penetration of β‑amyloid tracer 
into the brain parenchyma
Next, the periarterial distances of Aβ from the surface of the 
brain at 5 and 30 min after intracisternal injection were deter-
mined using the quantification method illustrated in Online 
resource 1. Normally, distributed data presented in the form 
of histograms show the  Log10 values.
Regional differences in distance of periarterial 
penetration of Aβ into the parenchyma after 5 min 
in 6–10‑week‑old mice
Soluble Aβ injected into the CSF was only observed along 
the walls of leptomeningeal and cortical arteries after 5 and 
30 min of injection. No Aβ was observed in the walls of capil-
laries or veins. The depth of penetration of Aβ along the walls 
of cortical arteries was calculated in eleven different brain 
regions. At 5 min post injection, there was no statistically sig-
nificant difference between the periarterial Aβ distance in the 
olfactory bulbs and the frontal, parietal, and entorhinal cor-
tices. However, the distance at which Aβ was detected in the 
walls of arteries was significantly greater in the visual cortex, 
caudoputamen, thalamus, pons and cerebellar molecular layer 
compared to the olfactory bulbs (P < 0.0001). The greatest dis-
tance at which Aβ was detected from the surface of the brain 
was 253.18 µm and this was observed in the pons. No Aβ was 
detected in the corpus callosum.
Regional differences in the distance of periarterial 
penetration of Aβ after 30 min in 6–10‑week‑old 
mice
Regional differences in the depth from the brain surface 
at which Aβ within the walls of arteries was located in the 
parenchyma at 30 min from the intracisternal injection, were 
largely similar to those detected after 5 min. The main differ-
ences were in greater depths of penetration in the olfactory 
bulbs and the cortical, subcortical and posterior brain regions. 
There was a statistically significant difference in the distance 
at which periarterial Aβ was detected within the parenchymal 
arteries in all eleven regions compared to the olfactory bulbs 
(P ≤ 0.0001), Fig. 4.
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Regional differences in the periarterial distance 
of Aβ penetration into the parenchyma 
in 24–30‑month‑old mice
After 5  min of injection into the cisterna magna of 
24–30-month-old mice, the greatest periarterial distance 
along which Aβ was detected was in the pons and the least 
was detected in the thalamus. The periarterial Aβ distance 
in the olfactory bulbs was significantly greater than the fron-
tal cortex and the thalamus, but significantly less than the 
caudoputamen, tectum/tegmentum and pons (P < 0.0001). 
The periarterial Aβ distance in the caudoputamen was sig-
nificantly higher than in the frontal cortex, thalamus and 
tectum/tegmentum.
At 30 min, the greatest periarterial distance at which Aβ 
was observed in the parenchyma was no longer in the pons 
but in the caudoputamen, followed by the pons. Similar to the 
young mice, the periarterial distance of Aβ was significantly 
greater after 30 min compared to 5 min in all of the brain 
regions analysed including the olfactory bulbs, frontal cortex, 
Fig. 2  Anatomical entry route of Aβ into old 24–30-month-old 
mouse brain from the CSF at 5 min post injection: a–c arteries show-
ing Aβ (red) along the walls of arterioles of 10–20  µm diameter 
labelled with collagen IV (blue) and smooth muscle actin (green); 
d an artery entering the cerebral cortex (arrow) showing Aβ (red) 
extending into the brain; e enlargement of the artery in (d) showing 
laminin α-2 staining in the glia limitans on the surface of the brain 
(green) and co-localisation of the amyloid with laminin α-2 in the 
vessel wall (yellow) as indicated by the arrow; f single optical section 
of artery in e; g single channel image of laminin α-2 from d; h single 
channel image of collagen IV from d; i single channel image of Aβ 
from d 
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caudoputamen, thalamus, tectum/tegmentum and pons (one-
way ANOVA, P < 0.0001), Fig. 5.
The comparison between the patterns of the periarterial 
distance of Aβ entry from the CSF into the parenchyma at 5 
and 30 min after intracisternal injection for both young and old 
mice is presented in Online Resource 3.
Discussion
The first two major objectives in the present study were: 
(1) to demonstrate by immunocytochemistry that the pial-
glial basement membranes are the entry route into the 
Fig. 3  Anatomical route for drainage of Aβ out of the brain following 
entry from the CSF at 30 min post injection in old 24–30-month-old 
mice: a An artery and vein at the surface of the brain. The artery is 
identified by smooth muscle cells in its wall (green). Aβ tracer (red) 
is present in a ladder-like pattern in the wall of the artery. Aβ (red) 
in the wall of a vein is only seen at the surface suggesting that the 
Aβ here has entered from the CSF and not drained from the brain. 
Only occasional veins had Aβ in their walls. b Enlargement of the 
artery in a showing the ladder-like distribution of Aβ that resembles 
the distribution of amyloid in CAA [29]. At the surface of the brain 
is a branch of a leptomeningeal artery showing the ladder-like dis-
tribution of smooth muscle cells in the tunica media. The Aβ is in 
the intramural periarterial drainage (IPAD) pathway; c macrophages 
take up Aβ tracer at 30 min after injection. The arrows indicate Aβ 
(red) within macrophages stained for the macrophage marker CD163 
(green); d astrocytes are stained for GFAP (green). Co-localisation 
(yellow) of Aβ and GFAP indicates uptake of Aβ tracer by perivas-
cular astrocytes
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brain for soluble tracers from the CSF and (2) to test 
the hypothesis that tracers entering the brain from the 
CSF drain out of the brain parenchyma along the IPAD 
pathways that are lymphatic drainage pathways from the 
brain for the elimination of fluid and solutes.
To fulfil these objectives, we performed multi-labelling 
immunocytochemistry and confocal microscope studies on 
Fig. 4  Periarterial penetration of Aβ is of greater distance after 
30  min than after 5  min in cortical, subcortical and posterior brain 
regions of young mice. Bar charts of periarterial Aβ distance against 
time after injection into cisternal CSF (5 and 30 min) in the olfactory 
bulbs (a), somatomotor area (b), somatosensory area and caudoputa-
men (c), thalamus and hypothalamus (d), superior colliculus, pon-
tine reticular nucleus, entorhinal and visual areas (e) and cerebellar 
molecular layer (f). Values are presented as mean ± SEM of untrans-
formed data, with p values indicated for log10-transformed data (one-
way ANOVA with Sidak’s post hoc)
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young 6–10-week-old mice and on aged 24–30-month-old 
mice, both at two separate time points of 5 and 30 min after 
injection of Aβ tracer into the CSF of the cisterna magna.
Our study showed similar but not exactly identical results 
in mice in the two age groups. We confirmed by immuno-
cytochemistry and confocal microscopy, our previous elec-
tron microscope studies that, within 5 min of injection into 
the CSF, tracer were present in the brain within basement 
membranes on the outer aspects of cortical artery walls. 
More exactly, the electron microscope study [24] and the 
present results using immunocytochemistry for α-2 laminin 
[9] identified tracer in pial-glial basement membranes. These 
results suggest that one pathway for entry of tracers into the 
brain from the CSF is along the pial-glial basement mem-
branes between the layer of pia mater and astrocytes in the 
perivascular glia limitans (Fig. 6). This entry pathway was 
observed in the young and in aged mice.
Basement membranes and cell components surrounding 
cortical arteries are compacted so that there is no perivas-
cular “space” for transport of tracers [23, 37]; transport 
appears to be along basement membranes as shown in the 
present study. This contradicts the statement in the glym-
phatic literature that there is transport of tracers into the 
brain along perivascular “spaces” [17]. These authors used 
low resolution two-photon microscopy which did not resolve 
the microanatomy of the perivascular compartment. Further-
more, the subarachnoid space appears to have been mistaken 
for perivascular space in the electron micrographs [17].
At 30 min following injection into the CSF of the cis-
terna magna, in the present study, Aβ tracer colocalised 
with collagen IV in basement membranes within the walls 
of arteries. These basement membranes are in the position 
of smooth muscle cell basement membranes in the tunica 
media of arteries [4, 14, 27, 29] and correspond to the intra-
mural peri-arterial drainage (IPAD) pathways that are the 
proposed route of drainage of interstitial fluid and solutes 
from the brain.
The pattern of distribution of Aβ tracer in the artery wall 
at 30 min after injection into cisternal CSF was similar in 
the young 6–10-week- and the old 24–30-month-old mice. 
Aβ tracer was located in the spirally arranged smooth mus-
cle cell basement membranes within the tunica media of 
arteries within the cerebral cortex. This is the same IPAD 
pathway identified previously by intracerebral injections of 
tracer in mice and the same IPAD pathway in which the Aβ 
is deposited in CAA [5, 19, 29]. Electron microscope studies 
of CAA have shown that fibrillary Aβ is initially deposited 
in the lamina densa that forms the junction zone between 
basement membranes of adjacent smooth muscle cells in the 
tunica media [12, 38].
With the increase in volume of deposited Aβ in CAA, the 
mass of Aβ separates the basement membranes of adjacent 
smooth muscle cells [5, 19]. Although adjacent basement 
membranes are fused at the lamina densa in a normal artery, 
it appears that the two parts of the basement membrane can 
be separated by the deposition of amyloid [12]. Neverthe-
less, co-localisation of tracer with laminin in previous stud-
ies [4] and collagen IV in the present study suggest that bulk 
flow of tracers, therefore, of ISF and other solutes, out of 
the brain is along basement membranes that form the IPAD 
pathways.
The results of the present investigation suggest a pos-
sible route for connection between the inflow of tracers 
from the CSF along pial-glial basement membranes and the 
outflow along smooth muscle cell basement membranes in 
the IPAD pathway. In the older 24-30-month-old mice, Aβ 
tracer injected into the CSF was located within astrocytes 
and in macrophages in the brain parenchyma at 30 min. 
Fig. 5  Regional differences in periarterial distance of penetration of 
Aβ at 5- and 30-min post-injection in old mice. a Schematic show-
ing a sagittal mouse brain section with five brain levels (I–V) from 
which distance measurements were taken in six brain regions at 5 min 
after injection of Aβ into cisterna magna. (Allen Institute for Brain 
Science. Allen Mouse Brain Atlas. Available from: http://mouse .brain 
-map.org/stati c/atlas .) b Bar charts of periarterial Aβ distance against 
time after injection into cisternal CSF (5 and 30 min) in the olfactory 
bulbs (teal), somatomotor area (green), caudoputamen (blue), thala-
mus (salmon), superior colliculus (pink) and pontine reticular nucleus 
(orange). Values are presented as mean ± SEM of untransformed data, 
with p values indicated for log10-transformed data (one-way ANOVA 
with Sidak’s post hoc)
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This suggests that tracer had entered the extracellular, ISF 
compartment of the brain and been taken up by these cells. 
Futhermore, Aβ, tracer was located in the walls of brain 
capillaries associated with collagen IV in the capillary base-
ment membranes. It seems most probable that the Aβ tracer 
drains out of the brain initially along basement membranes 
in the walls of cerebral capillaries and then along smooth 
muscle cell basement membranes in the walls of cerebral 
arterioles and arteries. This is effectively the same IPAD 
pathway identified for the outflow of tracers injected directly 
into the brain parenchyma [4].
Previous studies have suggested that tracers entering the 
brain from the CSF drain out of the brain along the walls 
of veins [17]. This suggestion is derived not from injection 
of tracers into the CSF but from intracerebral injections of 
tracer. Veins were not conclusively identified in these stud-
ies, and it is unclear whether the tracer was even present in 
the walls of blood vessels or in the surrounding brain tissue. 
In Iliff et al., [17] the veins were identified by the absence 
of NG2Ds-Red rather than immunocytochemistry for the 
absence of smooth muscle actin [17]. Recent studies dem-
onstrate that NG2Ds-Red is not specific for identification of 
arteries, so it is possible that some of the vessels that were 
NG2-DsRed negative may indeed have been smooth muscle 
actin positive arterioles [15].
It is also likely that in this study [17], tracer leaked from 
the brain into the CSF during the intracerebral injections 
due to the use of a large 33G needle for injecting a large 1 µl 
volume of tracer. This would account for the appearance of 
tracer as oval patches resembling macrophages surrounding 
veins in the subarachnoid space. Furthermore, the time of 
examination of the brain was one hour  rather than the much 
earlier time of 5 min at which it has been shown that tracers, 
injected intracerebrally, drain out of the brain along IPAD 
Arteriole
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CSF + ISF Tracers in the CSF enter the brain  along the Pial-Glial Basement 
Membrane
Tracers leave the brain along 
Intramural Peri-Arterial  Drainage 
(IPAD) pathways  in the smooth 
muscle cell basement 
membranes in the tunica media. 
Endothelium
BM1
Smooth muscle cell
BM2
BM3
Pia mater
BM4 Pial-glial basement membrane
Astrocyte processes of glia limitans
Perivascular 
macrophage
Capillary
(1)(2)
(3)
(4)
(5)
(6)
Capillary basement 
membrane
Pathways for influx of CSF into the brain and drainage of CSF/ISF out of the brain 
along periarterial basement membranes
Cerebral cortex
Fig. 6  Pathways for influx of CSF into the brain and drainage of CSF/
ISF out of the brain along capillary and periarterial basement mem-
branes. (1) Entry of tracers from the CSF into the brain along pial-
glial basement membranes on the outer aspects of artery walls. The 
sites of entry of tracer into the brain extracellular compartment are 
unclear and could be multiple. (2) CSF enters the brain parenchyma 
and (3) mixes with interstitial fluid (ISF). (4) The mixture of CSF/ISF 
diffuses through the narrow extracellular spaces of the brain to enter 
(5) basement membranes in the walls of capillaries to drain out of the 
brain along (6) basement membranes of smooth muscle cells in the 
tunica media in the walls of arterioles and arteries (IPAD pathway). 
Key to the microanatomy of the capillary and artery walls: BM1 
endothelial basement membrane. BM2 smooth muscle cell basement 
membrane identified in this study by the presence of collagen IV. 
BM3 basement membrane between pia mater (pink) and smooth mus-
cle cell. BM4 pia-glial basement membrane between the pia mater 
and the astrocytes of the glia limitans. In this study, BM4 is identified 
by the presence of α2-laminin [9, 13]. Proposed route of IPAD tracer 
is located in the capillary endothelial basement membrane (5) appar-
ently entering from the brain parenchyma. In the artery wall, tracer is 
observed in the basement membranes between smooth muscle cells 
(light purple) but not in the basement membranes on the outer aspect 
of the artery wall or in the endothelial basement membrane of the 
artery wall (both dull blue) [4, 27]. The light green arrow indicates 
the proposed intramural peri-arterial drainage (IPAD) pathway for 
fluid and solutes out of the brain
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pathways [4]. In the present study, tracer was only rarely 
detected in the walls of veins for short distances very near 
the surface of the brain and this probably represented incur-
sion of tracer from the subarachnoid space. For example, the 
vein in Fig. 3a shows a small amount of Aβ (red) in its wall 
near the surface of the brain but no Aβ in the wall further 
into the brain. This short ingress of tracer into the brain from 
the SAS along veins has been recorded in [17] and recent 
studies [1, 13, 27].
Other recent studies cast doubt upon the circulation of 
Aβ from the periarterial convective influx compartment to 
the perivenous compartment for clearance into the CSF [34, 
35]. Our results support the convective influx of Aβ along 
arterial perivascular compartments in the pial-glial basement 
membranes, but we did not observe perivenous clearance 
into the CSF. This field of work is significant not only for the 
pathogenesis of CAA, but also for the distribution of drugs 
into the parenchyma after intrathecal delivery, as well as for 
the interpretation of biomarkers in the CSF.
The third objective of the present study was to determine 
the range of depths of penetration of tracer alongside arter-
ies in different regions of the brain at the time points of 5 
and 30 min in young and aged mice. We demonstrated that 
the pons is the region with the highest penetration of Aβ at 
both ages at 5 min after intracisternal injection. Recently, we 
showed in vivo that entry of contrast agent is most efficient 
in the midbrain of dogs and the pial-glial basement mem-
branes were also thickest in the midbrain [10]. This sug-
gests that the brainstem is an area most efficiently reached by 
therapeutic agents from the CSF, most likely also explaining 
the success of intracisternally administered antisense oli-
gonucleotides in the treatment of spinal muscular atrophy 
(SMA) [6, 21]. SPINRAZA is an anti-sense oligonucleotide 
that alters the splicing of survival motor neuron (SMN) pre-
messenger RNA to increase production of full-length normal 
SMN protein. Following a randomized, double-blind, sham-
controlled study in infantile-onset SMA where SPINRAZA 
(www.spinr aza.com) was administered intrathecally, the 
motor milestones improved significantly and the numbers 
of deaths decreased. Our results suggest that it is possible for 
solutes to reach the neurons in the brainstem within 5 min 
increasing thus the understanding of how anti-sense oligo-
nucleotides that are in development for intrathecal adminis-
tration in the treatment of neurological diseases may reach 
their targets [31].
Although in the present study, the depth at which Aβ 
was observed in the brain increased after 30 min, most was 
observed in the pial-glial basement membranes of arteries. 
This suggests that therapeutic agents would need to then 
diffuse from the pial-glial basement membranes towards 
their target, reducing the concentration and therapeutic effi-
ciency. Only 10–15% of the intrathecally administered dose 
of proteins in cynomolgus monkeys was observed within the 
parenchyma at 2.5 h after injection of tracer into the CSF 
and by 24 h this decreased to 2% [25].
The exact dynamics of biomarkers in the CSF associated 
with neuropathological conditions remain unclear. Although 
with advancement of Alzheimer’s disease, there is a decrease 
in the amount of both Aβ1-40 and 1-42 in the CSF, there is 
a corresponding increase in total and phosphorylated forms 
of tau [16]. It is probable that the Aβ becomes entrapped in 
the IPAD pathways as CAA, and therefore, less Aβ is able 
to reach the CSF; this is in contrast to the more soluble tau 
that may be able to filter more readily along the chains of 
glycoproteins and proteoglycan components of the basement 
membranes surrounding smooth muscle cells.
In conclusion, we suggest that the present observations 
support the working hypothesis that tracers injected into 
the CSF pass into the brain along pial-glial basement mem-
branes on the outer aspects of cortical arteries, enter the 
brain parenchyma and drain out of the brain along pericap-
illary and periarterial basement membranes that form the 
IPAD pathway for the drainage of ISF and solutes from the 
brain. In older mice, this pathway is impaired, as by 30 min 
after intracisternal injection, the tracer is observed in the 
capillary basement membranes, as well as in astrocytes and 
macrophages.
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